Accordingly, AGPAT1 has been identified as a negative prognostic marker of CRC and was included in metabolic gene signatures that could help to classify CRC patients and be used for the development of precision therapies [82,83,84]. The gene discussed is AGPAT1; the disease is colorectal carcinoma.